돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 546569생성일: 2026년 10월 23일

3-Aminopyridine → 3-[1-(N-cyclopentylglycyl)-3,3-dimethyl-2,3-dihydro-1H-indol-6-yl]-5,5-dimethyl-1-{[2-(pyridin-3-ylamino)pyridin-4-yl]methyl}imidazolidine-2,4-dione

https://huagongshe.com/ko/reaction/546569

반응식

참여 물질

역할이름HCID투입량
반응물3-AminopyridineHCID 10009—
반응물Cesium carbonateHCID 10796—
반응물tert-butyl [2-(6-{3-[(2-chloropyridin-4-yl)methyl]-4,4-dimethyl-2,5-dioxo-imidazolidin-1-yl}-3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]cyclopentylcarbamateHCID 57626019—
반응물(9,9-dimethyl-9H-xanthene-3,6-diyl)bis(diphenylphosphine)HCID 86628973—
촉매palladium(II) acetateHCID 167845—
용매1,4-DioxaneHCID 31275—
생성물3-[1-(N-cyclopentylglycyl)-3,3-dimethyl-2,3-dihydro-1H-indol-6-yl]-5,5-dimethyl-1-{[2-(pyridin-3-ylamino)pyridin-4-yl]methyl}imidazolidine-2,4-dioneHCID 5762598541.3%

반응 단계

To a solution of 0.312 g of tert-butyl [2-(6-{3-[(2-chloropyridin-4-yl)methyl]-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl}-3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]cyclopentylcarbamate obtained in stage 1) of Example 3 in 12 mL of dioxane are successively added, under argon, 0.094 g of 3-aminopyridine, 0.028 g of (9,9-dimethyl-9H-xanthene-3,6-diyl)bis(diphenylphosphine) (Xantphos), 0.022 g of palladium acetate and 0.65 g of caesium carbonate. The reaction mixture is refluxed for 4 hours and then filtered, and the filtrate is concentrated under reduced pressure. The residue is taken up in 10 mL of dioxane, 12 mL of a 4N solution of hydrogen chloride in dioxane are then added and the reaction mixture is stirred at room temperature for 15 hours. After concentrating under reduced pressure, the residue is taken up in 40 mL of water, neutralized by addition of sodium hydrogen carbonate and extracted with three times 25 mL of dichloromethane. The combined organic phases are then washed with water, dried over magnesium sulphate filtered and concentrated under reduced pressure. The residue is triturated with diethyl ether and the solid obtained is filtered off and dried to give 0.12 g of 3-[1-(N-cyclopentylglycyl)-3,3-dimethyl-2,3-dihydro-1H-indol-6-yl]-5,5-dimethyl-1-{[2-(pyridin-3-ylamino)pyridin-4-yl]methyl}imidazolidine-2,4-dione, the characteristics of which are as follows:

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07935819B2
출처 데이터셋uspto-grants-2011_05
ORD IDord-50823883cdcc40d1a60b80f8ad9058dc
출처 메모uspto-grants-2011_05